Literature DB >> 22057047

Early stroke following acute myocardial infarction: incidence, predictors and outcome in six Middle-Eastern countries.

Osamah Albaker1, Mohammad Zubaid, Alawi A Alsheikh-Ali, Wafa Rashed, Muath Alanbaei, Wael Almahmeed, Sulaiman Z Al-Shereiqi, Kadhim Sulaiman, Awad Al Qahtani, Jassim Al Suwaidi.   

Abstract

BACKGROUND AND OBJECTIVES: Stroke is a potential complication of acute myocardial infarction (AMI). The aim of this study was to identify the incidence, risk factors predisposing to stroke and in-hospital outcome during the index admission with AMI among patients in the Middle East.
METHODS: For a period of 6 months in 2006 and 2007, 5,833 consecutive AMI patients were enrolled from 64 hospitals in 6 Middle East countries.
RESULTS: The incidence of in-hospital stroke following AMI was 0.85%. Most cases were ST segment elevation AMI-related and ischemic in nature. Patients with in-hospital stroke were older than patients without stroke and were more likely to be female (36 vs. 18.6%, p = 0.0033). They were also more likely to have diabetes mellitus, dyslipidemia, prior AMI, or percutaneous/surgical coronary revascularization. Patients with stroke were more likely to present with advanced Killip class II-IV, higher mean heart rate and higher serum creatinine. Independent predictors of stroke were age, prior stroke, prior coronary artery bypass surgery, anterior AMI and systolic blood pressure >190 mm Hg on presentation. Early administration of statins was independently associated with reduced stroke risk (odds ratio, OR, 0.4, 95% confidence interval, CI, 0.19-0.90, p = 0.025). Stroke was fatal in 44% of the cases and was independently associated with in-hospital mortality (adjusted OR 12.5, 95% CI 5.7-27.4, p < 0.01).
CONCLUSION: There is a low incidence of in-hospital stroke in Middle-Eastern patients presenting with AMI but with very high fatality rates. Early statin therapy was associated with a significant reduction in stroke risk. Future work should be focused on reducing the risk and improving the outcome of this devastating complication.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057047     DOI: 10.1159/000330344

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  5 in total

1.  Immediate and one-year outcome of patients presenting with acute coronary syndrome complicated by stroke: findings from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2).

Authors:  Jassim Al Suwaidi; Khalid Al Habib; Nidal Asaad; Rajvir Singh; Ahmad Hersi; Husam Al Falaeh; Shukri Al Saif; Ahmed Al-Motarreb; Wael Almahmeed; Kadhim Sulaiman; Haitham Amin; Jawad Al-Lawati; Norah Q Al-Sagheer; Alawi A Alsheikh-Ali; Amar M Salam
Journal:  BMC Cardiovasc Disord       Date:  2012-08-16       Impact factor: 2.298

2.  Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.

Authors:  Hadi A R Khafaji; Kadhim Sulaiman; Rajvir Singh; Khalid F AlHabib; Nidal Asaad; Alawi Alsheikh-Ali; Mohammed Al-Jarallah; Bassam Bulbanat; Wael AlMahmeed; Mustafa Ridha; Nooshin Bazargani; Haitham Amin; Ahmed Al-Motarreb; Hussam AlFaleh; Abdelfatah Elasfar; Prashanth Panduranga; Jassim Al Suwaidi
Journal:  BMJ Open       Date:  2015-04-23       Impact factor: 2.692

3.  Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study.

Authors:  Sven-Erik Eriksson
Journal:  Brain Behav       Date:  2016-11-28       Impact factor: 2.708

4.  Measuring of quality of care in patients with stroke and acute myocardial infarction: An application of algebra effectiveness model.

Authors:  Kyoung Hee Cho; Chung Mo Nam; Sang Gyu Lee; Tae Hyun Kim; Seon-Heui Lee; Eun-Cheol Park
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Gulf CARE: Heart failure in the Middle East.

Authors:  Mohamed Hassan
Journal:  Glob Cardiol Sci Pract       Date:  2015-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.